It depends on the population and the use case. Here's a breakdown:
User Group | Essential (Yes/No) | Why |
---|---|---|
Patients with obesity (BMI > 30) | ✔️ Yes | For individuals with severe obesity, weight loss is critical to prevent complications like heart disease, fatty liver, or diabetes. Retatrutide may offer a powerful solution. |
Type 2 diabetes patients | ✔️ Yes | Especially for patients who do not respond well to existing GLP-1 drugs (like Semaglutide), Retatrutide could be a more effective option—controlling both blood sugar and body weight. |